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ABSTRACT The Latin American 2015–2016 Zika virus (ZIKV) outbreak was associ-
ated with an increase in microcephaly predominantly in northeastern Brazil. To com-
paratively investigate infectious causes of congenital malformations, we performed a
nested case-control study in 32 mothers of cases of suspected congenital Zika syn-
drome (CZS) and 160 age-matched controls from Bahia, northeastern Brazil. We col-
lected clinical and imaging data and assessed past exposure to ZIKV, Chikungunya
virus (CHIKV), dengue virus, and 8 established TORCH (Toxoplasma gondii, Treponema
pallidum, rubella virus, cytomegalovirus, herpes simplex virus 1 [HSV-1] and HSV-2,
varicella-zoster virus, parvovirus B19) pathogens using multiple serological tests. Het-
erogeneous symptoms prevented unequivocal diagnosis of CZS on clinical grounds.
Only ZIKV and CHIKV seroprevalence rates differed signiﬁcantly between cases and
controls (93.8% versus 67.8% for ZIKV [Fisher’s exact text, P  0.002] and 20.7% ver-
sus 8.2% for CHIKV [2, P  0.039]). High ZIKV seroprevalence rates in cases could
not be explained by previous dengue virus infections potentially eliciting cross-
reactive antibody responses affecting ZIKV serological tests. In conditional logistic re-
gression analyses, only ZIKV was signiﬁcantly associated with congenital malforma-
tions (P  0.030; odds ratio, 4.0 [95% conﬁdence interval, 1.1 to 14.1]). Our data
support an association between maternal ZIKV exposure and congenital malformations.
Parallels between the discrepant ZIKV and CHIKV seroprevalence rates between cases
and controls and similar seroprevalence rates between cases and controls for the sexu-
ally transmitted T. pallidum and HSV-2 may suggest the occurrence of predominantly
vector-borne transmission in our study population. High seroprevalence of TORCH
pathogens suggests that exhaustive diagnostics will be necessary in the aftermath of the
ZIKV outbreak and provides baseline data for longitudinal studies on ZIKV pathogenesis.
IMPORTANCE The Latin American Zika virus (ZIKV) outbreak had a major impact on
reproductive health worldwide. The reasons for the massively increased reports of
neonatal microcephaly in northeastern Brazil are still unclear. Beyond the technical
limitations of laboratory diagnostics, unambiguous diagnosis of ZIKV as the cause of
congenital malformations is hampered by similar clinical pictures elicited by other
pathogens known as TORCH pathogens. We performed a case-control study compar-
ing mothers of children with congenital malformations to age-matched controls
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from Salvador, Brazil, one of the areas most extensively affected by the ZIKV out-
break. The ZIKV and Chikungunya virus seroprevalence rates differed signiﬁcantly,
whereas the levels of maternal exposure to TORCH pathogens were similar between
cases and controls. Our data support a link between maternal ZIKV infection and
congenital malformations and suggest the occurrence of predominantly vector-
borne ZIKV transmission in these cases. In addition, some highly prevalent TORCH
pathogens may be misinterpreted as representative of ongoing ZIKV activity in the
absence of exhaustive diagnostics in northeastern Brazil.
KEYWORDS Brazil, TORCH, Zika virus, microcephaly, parturient
During the 2015–2016 Zika virus (ZIKV) outbreak, a 20-fold increase in the incidenceof neonatal microcephaly was observed after the large ﬁrst epidemic wave in
northeastern Brazil (1–3). In addition to microcephaly, ZIKV causes other fetal abnor-
malities summarized as congenital Zika syndrome (CZS), including skull and brain
deformities, ocular abnormalities, arthrogryposis, and spasticity (4).
Despite the experimental evidence supporting ZIKV neuropathogenicity (5, 6),
proving the etiologic role of ZIKV in neonates with neurological malformations is
challenging. Laboratory diagnosis of ZIKV is hampered by the low sensitivity and
speciﬁcity of virological tests (7). In addition, teratogenic substances and genetic
disorders (8), as well as several pathogens other than ZIKV, can cause similar clinical
presentations in fetuses and neonates (9, 10). These pathogens, grouped under the
acronym TORCH, include, among others, Toxoplasma gondii, Listeria monocytogenes,
Treponema pallidum, rubella virus (RUBV), cytomegalovirus (CMV), herpes simplex
virus-1 (HSV-1) and HSV-2, varicella-zoster virus (VZV), and parvovirus B19 (PV-B19) (9).
In Brazil, routine antenatal screening is mainly performed for T. pallidum and T. gondii.
In cases of suspected congenital malformations, additional laboratory testing is performed
but usually does not include all TORCH pathogens. Additionally, usage of different methods
hinders comparisons of laboratory results for these pathogens across sites. Information on
TORCH pathogens and their potential association with suspected cases of ZIKV-associated
congenital malformations is thus scarce. In Brazil, a case-control study performed in Recife
reported no statistically signiﬁcant difference in the levels of maternal exposure to RUBV,
CMV, and T. gondii in 32 cases of suspected CZS and 64 controls (11). Additionally, cohort
studies in the Caribbean and Rio de Janeiro, Brazil, failed to observe fetal abnormalities in
11 combined cases of ZIKV coinfections with HIV-1, CMV, T. gondii, or T. pallidum (12, 13).
In contrast, a cohort study performed in São Paulo, Brazil, reported one case of ZIKV
coinfection with T. gondii with abnormal neuroimaging ﬁndings (14). TORCH pathogens
may be overlooked as causes of congenital malformations attributed to ZIKV during the
outbreak or unrecognized cofactors of suspected CZS or may impact clinical presentations
in cases of suspected CZS in northeastern Brazil.
To investigate exposure to the emerging arboviruses ZIKV and CHIKV in comparison
to exposure to established TORCH pathogens, we conducted exhaustive serological
investigations in 32 mothers of children born with congenital malformations (termed
cases) and 160 mothers of children born without congenital malformations (termed
controls) from a highly ZIKV-affected region in northeastern Brazil (1). For every case, 5
controls were matched by age (2.0 years). The resulting age distributions of cases
(mean, 26.8 years; standard deviation [SD], 6.6) and controls (mean, 28.9 years; SD, 6.6)
did not differ signiﬁcantly (t test, P  0.09). Beyond age, data on education and
ethnicity were available for around 70% of cases and controls. The study comprised
mainly mixed-race individuals (80.0% of cases and 92.2% of controls; 2, P 0.066) with
completed secondary schooling (85.7% of cases and 92.2% of controls; Fisher’s exact
test; P  0.402).
All cases showed abnormal but heterogeneous clinical and neuroimaging ﬁndings,
preventing unequivocal diagnosis of suspected CZS based on clinical presentation (see
Table S1 in the supplemental material). Common ﬁndings included microcephaly
(81.3%; 26/32) followed by intracranial calciﬁcations (75.0%; 24/32), ventriculomegaly
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(56.3%; 18/32), dysgenesis of the corpus callosum (28.1%; 9/32), and Dandy-Walker-like
malformations (18.8%; 6/32). Hydranencephaly, porencephaly, and hydrocephalus (66.6%;
4/6), severe intracranial calciﬁcations (66.6%; 4/6), and reduction of encephalic mass (50.0%;
3/6) were reported from 6 cases classiﬁed as suspected CZS despite normal head circum-
ference at birth, consistent with a recent case series from the Caribbean (15).
The difference in ZIKV seroprevalence rates between cases (93.8%) and controls
(67.8%) was statistically signiﬁcant (Fisher’s exact text, P  0.002, power  93.9%). A
similar discrepancy was observed for CHIKV seroprevalence rates between cases (20.7%)
and controls (8.2%; 2, P 0.039, power 53.0%), suggesting higher exposure of cases to
these vector-transmitted pathogens. Nonetheless, only ZIKV was signiﬁcantly associated
with congenital malformations in conditional logistic regression analyses (P  0.030; odds
ratio, 4.0 [95% conﬁdence interval {CI}, 1.1 to 14.1]). High ZIKV seroprevalence in cases was
unlikely to be explained by potential cross-reactive antibodies affecting ZIKV
serological tests elicited by previous dengue virus (DENV) infections, because DENV
seroprevalence was higher in controls (89.1%) than in cases (74.1%; 2, P  0.1).
Seroprevalence of TORCH pathogens in cases and controls ranged from very high
(87.5% to 97.5%) for HSV-1, RUBV, VZV, and CMV to moderate (28.1% to 59.4%) for
Chlamydia trachomatis, Bordetella pertussis, T. gondii, PV-B19, and HSV-2 and low (0.0%
to 1.3%) for T. pallidum, and no signiﬁcant differences were found between groups
(Fig. 1) (Table 1).
FIG 1 Seroprevalence rates of cases and controls. Seroprevalence rates are shown with adjusted Wald conﬁdence intervals (column
lines). Asterisks denote a P value of 0.05. Fisher’s exact tests were done when any cell count was below 5; otherwise, 2 tests were
done to compare seroprevalence rates.
TABLE 1 Seroprevalence rates in cases and controls
Pathogen
Seroprevalence
cases (%) 95% CIa
Seroprevalence
controls (%) 95% CI
Odds
ratiob 95% CI Pd
ZIKV 93.8 78.8–99.3 67.8 59.9–74.8 7.1c 1.6–31.1 0.002
CHIKV 20.7 9.5–38.8 8.2 5.2–14.8 2.9c 1.0–8.4 0.039
DENV 74.1 55.1–87.1 89.1 79.2–95.6 0.3 0.0–1.0 0.100
RUBV 90.6 75.0–97.5 97.5 93.5–99.2 0.2 0.0–1.2 0.092
HSV-1 93.8 78.8–99.3 95.0 90.3–97.6 0.8 0.1–3.9 0.673
HSV-2 28.1 15.4–45.5 47.1 32.1–47.1 0.6 0.3–1.4 0.230
VZV 87.5 71.3–95.6 94.4 89.5–97.2 0.4 0.1–1.5 0.236
CMV 96.9 82.9–100.0 96.9 92.7–99.0 1.0 0.1–8.9 1.000
PV-B19 31.3 17.8–48.7 35.6 28.6–43.3 0.8 0.4–1.8 0.635
C. trachomatis 46.9 30.9–63.6 48.1 40.5–55.8 0.9 0.4–2.0 0.897
B. pertussis 56.3 39.3–71.9 59.4 51.8–66.7 0.9 0.4–1.9 0.742
T. pallidum 0.0 0.0–9.3 1.3 0.0–4.7 0.9 0.0–20.8 1.000
T. gondii 53.1 36.5–69.1 58.7 51.0–66.1 0.8 0.4–1.7 0.556
aCI, conﬁdence interval.
bData represent results from bivariate comparisons.
cIn conditional logistic regression analyses, odds ratios were as follows: ZIKV (P  0.030; odds ratio, 4.0 [95%
CI, 1.1 to 14.1]) and CHIKV (P  0.084; odds ratio, 2.8 [95% CI, 0.1 to 9.2]).
dData were calculated using 2 tests and Fisher’s exact tests when any cell count was below 5. Bold type
denotes statistical signiﬁcance.
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Seroprevalence rates from our study were consistent with previous studies showing
high (87.8%) VZV seroprevalence (16), moderate (64.9%) T. gondii seroprevalence (17),
and low (2.8%) T. pallidum seroprevalence (18) in northeastern Brazilian adult women,
suggesting robustness of our results. In the Zika case-control study performed in Recife,
northeastern Brazil, the seroprevalence of T. gondii in cases and controls was 44% to
53% and thus was not signiﬁcantly different from the range seen in our study (2, P 
0.05) (11). However, the seroprevalence rates of CMV (88% to 76%) and RUBV (63% to
76%) were lower in both cases and controls from Recife than in our study (Table 1; 2,
P  0.05) (11). These differences might be explained by variations in study designs,
regional differences, and differential performance of the diagnostic assays used in
routine antenatal screening compared to our targeted serological investigation. Of
note, since the Brazilian health system performs routine vaccination for VZV, RUBV, and
B. pertussis, we cannot differentiate immune responses elicited by vaccination from
those elicited by infection with wild-type pathogens (19).
The factors underlying the increase in potentially ZIKV-associated microcephaly
cases in northeastern Brazil remain unclear. Since Bahia and several other northeastern
Brazilian states are among the poorest regions of Brazil, poverty may be a general and
yet unspeciﬁc effect modiﬁer of ZIKV-associated microcephaly (1). The similarities in
ZIKV and CHIKV seroprevalence patterns suggest a relatively higher exposure of cases
to the main mosquito vector, Aedes aegypti. This may be potentially associated with
lower socioeconomic status, implying residence in more densely populated areas with
less-regular garbage recollection, providing enhanced availability of virus for mosquito
vectors and higher mosquito density. This hypothesis is consistent with area-level
analyses of socioeconomic factors affecting ZIKV exposure in Bahia (1) and affecting
occurrence of cases of microcephaly in Recife (20).
Sexual ZIKV transmission has been previously described (21) and may play an
important role in ZIKV congenital pathogenesis. However, similar levels of exposure of
cases and controls to sexually transmitted infections suggest predominantly vector-
borne ZIKV transmission in our study population. Of note, our results cannot be
extrapolated to other geographical settings, since prevalence rates of TORCH patho-
gens and ZIKV might differ considerably between regions. Studies comparing levels of
ZIKV seroprevalence in groups of sexually active and non-sexually active populations
and in different social strata would be desirable to assess the signiﬁcance of sexual ZIKV
transmission per site.
Our study was limited by lack of routine screening for genetic and environmental
causes of congenital malformations and by the absence of samples longitudinally
collected from mothers during pregnancy and from neonates after birth, which hin-
dered deﬁnite distinction between lifetime exposure and acute maternal infection
during pregnancy potentially leading to congenital infection of the fetus. The strengths
of our study included the exhaustive screening performed in an age-matched cohort,
usage of only one test for TORCH pathogens to minimize biases that could distort test
accuracy and reproducibility (22), and usage of multiple serological methods to accu-
rately detect arbovirus exposure.
Our data strongly support ZIKV infection as a cause of severe congenital malforma-
tions in northeastern Brazil. Our baseline data for TORCH pathogens will inform
subsequent epidemiological studies investigating ZIKV pathogenesis and the apparent
accumulation of congenital malformations observed in northeastern Brazil (23). High
TORCH seroprevalence rates suggest frequent exposure to TORCH pathogens in north-
eastern Brazil that must not be interpreted as evidence for ongoing ZIKV activity in the
region without exhaustive diagnostics.
Study population. The nested case-control study encompassed 32 mothers of
children born with congenital malformations and 160 mothers of children born without
congenital malformations attending the University of Bahia Climério de Oliveira ma-
ternity ward. The study was approved by the Institutional Research Ethics Board under
protocol no. 1.408.49. Cases and controls were sampled at the time of delivery during
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the same time period between May 2015 and October 2016. All patients who were
attended to during the study period accepted participation in the protocol. Micro-
cephaly cases were identiﬁed when the measurement of the cephalic circumference
was 2 standard deviations below that of the corresponding gestational age, based on
intergrowth charts from the World Health Organization in addition to clinical and
imaging data (Table S1) (24).
Serology. Commercially available IgG enzyme-linked immunosorbent assays (ELI-
SAs) for ZIKV and CHIKV were used according to the manufacturer’s instructions
(Euroimmun, Lübeck, Germany). Due to potential cross-reactivity of ZIKV- and DENV-
speciﬁc antibodies in serological assays (1), 50% plaque-reduction neutralization tests
(PRNT50) were done for ZIKV as described previously (7). Only study participants who
yielded positive ZIKV test results in both ELISA and PRNT50 were considered ZIKV
positive. To test for exposure to the endemic DENV, we performed an in-house
competitive ELISA that uses a mutant envelope antigen of DENV designed to be robust
against cross-reactivity with ZIKV-speciﬁc antibodies, as previously described (25). Due
to insufﬁcient sample volumes, only 27 cases and 135 corresponding controls matched
1:5 were tested against DENV. Testing for TORCH pathogens was done using a
commercially available immunoblot test (Euroline [anti-TO.R.C.H.-10 proﬁle]; Euro-
immun) which detects IgG antibodies against T. gondii, RUBV, CMV, HSV-1, HSV-2,
VZV, PV-B19, and T. pallidum (the classical TORCH pathogens) as well as Bordetella
pertussis and Chlamydia trachomatis (which cause severe disease in neonates).
Automated readout of scanned immunoblots was performed using EUROLineScan
software (Euroimmun).
Statistical analyses. Bivariate analyses were done using GraphPad Prism 5 (Graph-
Pad Software, Inc., La Jolla, CA, USA) and conditional logistic regression with forward
exclusion of variables in SPSS V23 (IBM, Ehningen, Germany) using the variables with P
values of 0.05 in bivariate analyses, and power was calculated using OpenEpi 3.01.
Statistics were calculated with 95% conﬁdence intervals.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mSphere.00278-18.
TABLE S1, PDF ﬁle, 0.1 MB.
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